ANGO vs VRTX · rev $292.5M vs P/E 30, rev $12.00B
AngioDynamics Inc (ANGO) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ANGO currently screens at market cap $378.5M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ANGO and VRTX stock pages for the full models.
Not investment advice.